0.00

100.00% -3.18

Esperion Therapeutics Inc (ESPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ESPR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.18

Aprire:

Volume 24 ore:

Relative Volume:

0.00

Capitalizzazione di mercato:

$819.46M

Reddito:

$418.24M

Utile/perdita netta:

$-7.42M

Rapporto P/E:

0.00

EPS:

-0.1034

Flusso di cassa netto:

$-10.88M

1 W Prestazione:

-100.00%

1M Prestazione:

-100.00%

6M Prestazione:

-100.00%

1 anno Prestazione:

-100.00%

Intervallo 1D:

$0.00

Intervallo di 1 settimana:

$0.00

Portata 52W:

$0.00

$4.175

Esperion Therapeutics Inc Stock (ESPR) Company Profile

Nome

Esperion Therapeutics Inc

Settore

Healthcare (1085)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

734-887-3903

Indirizzo

3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI

Dipendente

294

Cinguettio

@esperioninc

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

ESPR's Discussions on Twitter

Compare ESPR vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ESPR Esperion Therapeutics Inc	0.00	819.46M	418.24M	-7.42M	-10.88M	-0.1034
TAK Takeda Pharmaceutical Co Adr	16.93	55.69B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.905	43.77B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.33	36.19B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.27	32.25B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	515.99	26.29B	3.17B	1.29B	1.01B	27.09

Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-25	Iniziato	Piper Sandler	Overweight
2024-12-18	Iniziato	Goldman	Neutral
2024-12-17	Iniziato	Cantor Fitzgerald	Overweight
2024-06-20	Downgrade	BofA Securities	Neutral → Underperform
2024-01-03	Downgrade	BofA Securities	Buy → Neutral
2023-11-20	Ripresa	JP Morgan	Neutral
2023-08-01	Aggiornamento	Northland Capital	Under Perform → Market Perform
2023-06-15	Aggiornamento	BofA Securities	Underperform → Buy
2023-03-16	Downgrade	BofA Securities	Neutral → Underperform
2023-03-16	Downgrade	Northland Capital	Market Perform → Under Perform
2023-03-07	Aggiornamento	Credit Suisse	Underperform → Neutral
2023-02-27	Ripresa	BofA Securities	Neutral
2023-02-24	Aggiornamento	Jefferies	Hold → Buy
2023-02-03	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-08-03	Downgrade	Credit Suisse	Neutral → Underperform
2022-05-05	Aggiornamento	JP Morgan	Underweight → Neutral
2022-03-10	Iniziato	H.C. Wainwright	Buy
2021-10-19	Downgrade	Credit Suisse	Outperform → Neutral
2021-10-14	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2021-05-05	Downgrade	Stifel	Buy → Hold
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-03-11	Iniziato	Morgan Stanley	Equal-Weight
2021-02-12	Downgrade	Jefferies	Buy → Hold
2021-02-09	Downgrade	Goldman	Neutral → Sell
2021-01-15	Downgrade	BofA Securities	Buy → Neutral
2020-11-10	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-09-29	Ripresa	JP Morgan	Underweight
2020-08-11	Downgrade	Credit Suisse	Outperform → Neutral
2020-04-01	Ripresa	BofA/Merrill	Buy
2020-03-17	Aggiornamento	Citigroup	Neutral → Buy
2020-02-24	Downgrade	Northland Capital	Outperform → Market Perform
2020-02-14	Downgrade	Citigroup	Buy → Neutral
2019-09-16	Aggiornamento	Goldman	Sell → Neutral
2019-05-29	Downgrade	Goldman	Neutral → Sell
2019-05-06	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-04-26	Aggiornamento	Goldman	Sell → Neutral
2019-03-13	Aggiornamento	JP Morgan	Underweight → Neutral
2019-01-07	Reiterato	Needham	Strong Buy
2018-12-13	Iniziato	Goldman	Sell
2018-10-29	Aggiornamento	Northland Capital	Market Perform → Outperform
2018-10-16	Iniziato	BTIG Research	Buy
2018-08-17	Aggiornamento	Citigroup	Neutral → Buy
2018-07-11	Downgrade	Northland Capital	Outperform → Market Perform
2018-05-03	Downgrade	JP Morgan	Neutral → Underweight
2018-05-02	Downgrade	BofA/Merrill	Buy → Underperform

Mostra tutto

Esperion Therapeutics Inc Borsa (ESPR) Ultime notizie

Jul 27, 2026